Meanwhile, several studies have reported that FTO has tumor suppressor activity and is inversely correlated with tumor progression in ovarian cancer, hepatocellular carcinoma, intrahepatic cholangiocarcinoma and renal cell carcinoma [19–22]. This evidence concerns the gene FTO and ovarian carcinoma.